Catherine Eagle
Catherine has over 10 years of experience in the biotech industry, primarily in drug discovery with a focus on immuno-oncology and translational science. Catherine has an MSc by Research in cancer cell biology from the University of Bristol. She has expertise in establishing methods to assess drug mechanism, target engagement and PD biomarkers in both […]
William Drewe
William joined Medicines Discovery Catapult (MDC) in 2021 and is a member of the Business Development Team supporting MDC’s Translational Imaging capability. In this role William works to support pharmaceutical companies, SMEs and academic researchers develop and execute pre-clinical imaging studies by connecting them with MDC’s expertise, technology and wet-lab capabilities. William has a research […]
Jonathan Thomas
Since joining Medicines Discovery Catapult in April 2022 as a Business Development Manager, Jonathan has worked with the Biomarkers team, supporting SMEs, academics, and drug discovery researchers in identifying suitable biomarkers and clinical approaches for their drug or asset development. Jonathan’s passion for innovation has led him to excel in commercial roles within the Life […]
Timothy Rudd
Timothy is an expert in Next Generation Sequencing (NGS) technology and library preparation methods; his experience developed through 5 years within genomics service and scientific positions, utilising instruments from several leading genomics companies, including Illumina, 10X Genomics and MGI tech. After completing an epigenetics Honours project within Professor Stan Gronthos’ Mesenchymal Stem Cell Laboratory (South […]
Regine Anderson
After completing a Master’s Degree in Advanced Biomedical Sciences at De Montfort University, Regine began working as a biobank tissue co-ordinator for Nottingham University Hospitals, managing donor consent and tissue preservation. She later joined the University Hospitals of Leicester as part of a team enlisted to manage an Emergency Department ‘hot’ lab, performing urgent biochemistry […]
Dr Tara Bowen
Dr Tara Bowen obtained her PhD in Biosciences from the University of Birmingham in 2023. As part of a collaboration between Prof Mark Viant’s Metabolomics and System Toxicology laboratory and AstraZeneca, Tara’s research focused on developing and implementing mass spectrometry-based metabolomics workflows as a strategy towards discovering predictive biomarkers of drug-induced cardiotoxicity. Tara’s current focus at […]
Dr Robert Pedley
Robert joined Catapult in 2023 following a PhD in molecular Cancer Studies at the University of Manchester, investigating spatiotemporal protein-protein interactions in response to cytotoxic chemotherapies, and postdoctoral research posts utilising spatial biology techniques (high-plex immuno-staining, laser-capture microdissection in conjunction with LC-MS/MS) to identify biomarker of cancer risk in at-risk patient cohorts. Robert’s current interests […]
Dr Nisha Ponnappan
Nisha joined as a scientist at MDC in 2021 after obtaining her PhD in Biological Sciences from Indian Institute of Technology Delhi. Her academic research focussed on identifying and characterising small peptide sequences from animal toxins that can act as drug delivery vectors in mammalian cells. The work led to an award of patent for […]